Valgan Tablet

Regulated Product — Business License Required

B2B and export product information for licensed and authorized business customers. Contact our team regarding bulk supply, documentation, and applicable commercial, import, and export requirements. This page is not a storefront and no purchasing, checkout, or pricing is offered here.

Product photography not yet supplied — this space will show official packaging imagery once provided by the business.

Product Overview

Valgan Tablet contains valganciclovir, an antiviral medicine. Its labelling describes it for the treatment of cytomegalovirus (CMV) infection of the retina in adults who have acquired immunodeficiency syndrome (AIDS), and for the prevention of CMV disease in patients who have received an organ transplant from a CMV-positive donor. It is described as stopping the virus from multiplying, and is taken with food.

Active ingredient
Valganciclovir (as hydrochloride)
Dosage form
Oral film-coated tablet
Therapeutic class
Antiviral (nucleoside analogue)
Regulatory status
Prescription / regulated — confirmed per enquiry and destination market
Availability
Confirmed per enquiry

Product Information

The following description reflects information associated with valganciclovir and this product’s labelling. It has not been independently clinically verified by SDO Pharma and is provided for business and product-identification purposes only. It is not medical advice and does not replace the manufacturer’s official prescribing information.

Described Uses

  • Described for the treatment of CMV retinitis in adults with AIDS
  • Described for the prevention of CMV disease in organ transplant recipients from a CMV-positive donor
  • Described as preventing the virus from multiplying in the body’s cells
Note: SDO Pharma has not independently verified the manufacturer’s efficacy claims for this product and makes no additional medical or clinical claims beyond what is described here. We do not claim FDA, UAE, EU, or other specific regulatory approval for this product unless independently verified. This is a prescription / regulated-status product; patient dispensing is the responsibility of the licensed business customer, not SDO Pharma.

Described Dosage & Administration

  • Swallowed whole with water and taken with food; tablets should not be crushed, broken, or chewed
  • The dose and duration are set by the doctor according to treatment progress
  • No dose should be skipped and the full course should be completed, even if the patient feels better

Described Side Effects

Commonly described side effects include:

  • Diarrhoea
  • Fever
  • Vomiting
  • Anaemia (low number of red blood cells)
  • Decreased white blood cell count
  • Low blood platelet count
  • Difficulty sleeping (insomnia)
  • Tremors

Effects on blood cells are described as needing monitoring. Any severe, persistent, or unexpected reaction requires prompt medical attention.

Precautions

  • A complete medical history and records, with current medicines, should be shared with the doctor
  • The doctor should be informed if the patient is pregnant, as it is described as able to harm the baby; the same applies to breastfeeding
  • Blood counts are described as monitored during treatment
  • Any persistent or severe side effect should be reviewed by a clinician

This summary is provided for informational purposes only and does not replace the manufacturer’s official product labelling or professional medical advice.

B2B, Import & Export

B2B, Import & Export Enquiries

SDO Pharma supports business enquiries for pharmaceutical products, including bulk and export supply, subject to applicable licensing, regulatory, import, and export requirements. Requirements vary according to the destination market and the nature of the transaction.

We do not claim that this product is available for import into every country, and we do not claim FDA, UAE, EU, or other specific regulatory approval unless independently verified. Applicable documentation — including a valid Drug License, tax registration, and Importer Exporter Code (IEC) where relevant — is discussed directly with our team as part of the enquiry process. This is a regulated / prescription-status product supplied only to licensed and authorized business customers; SDO Pharma does not sell it directly to individual patients or consumers. See our Regulated Products Policy.

Product Enquiry

Request Product Information

Interested in this product for your business? Submit your enquiry and our team will contact you regarding bulk supply, documentation, and applicable requirements.

Frequently Asked Questions

Per its labelling it contains valganciclovir and is used to treat CMV retinitis in adults with AIDS and to prevent CMV disease in organ transplant recipients from a CMV-positive donor. SDO Pharma has not independently verified the manufacturer’s claims and does not claim any specific regulatory approval unless independently confirmed.

Its labelling describes it as swallowed whole with water and taken with food, not crushed, broken, or chewed. No dose should be skipped and the full course should be completed.

Licensed and authorized business customers can submit the product enquiry form above or contact our team directly. Product availability, documentation, and supply arrangements are confirmed per enquiry.

Availability depends on the destination market’s regulatory requirements and cannot be confirmed without a direct enquiry. See our B2B, Import & Export Enquiries section above.

Explore More

Related Product Categories

SDO Pharma works across several pharmaceutical and healthcare product categories for business customers.

View Products & Services